ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Net margin 2022–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) net profit margin by fiscal year — reported net income divided by reported revenue.
-4.3%FY2025 · since FY2022: -8449.8% → -4.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.3% | +67.0 pp |
| FY2024 | -71.3% | +368.5 pp |
| FY2023 | -439.8% | +8010.0 pp |
| FY2022 | -8449.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARQT financial trends
ARQT RevenueARQT Net incomeARQT Gross profitARQT Gross marginARQT Operating incomeARQT Operating marginARQT Operating cash flowARQT Free cash flowARQT Capital expendituresARQT Return on equityARQT Stock buybacksARQT Dividends paidARQT Total assetsARQT Total liabilitiesARQT Shareholders’ equityARQT overview →